+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

Type 2 Diabetes - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1251 Pages
  • Global
From
Human Reproductive Technologies: Products and Global Markets - Product Thumbnail Image

Human Reproductive Technologies: Products and Global Markets

  • Report
  • July 2022
  • 193 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Global Erectile Dysfunction Drugs Market by Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Erectile Dysfunction Drugs Market by Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 180 Pages
  • Global
From
Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Erectile Dysfunction Market - Global Outlook and Forecast 2021-2026 - Product Thumbnail Image

Erectile Dysfunction Market - Global Outlook and Forecast 2021-2026

  • Report
  • February 2021
  • 345 Pages
  • Global
From
Premature Ejaculation Disorder Market in US 2024-2028 - Product Thumbnail Image

Premature Ejaculation Disorder Market in US 2024-2028

  • Report
  • November 2023
  • 152 Pages
  • United States
From
Global Premature Ejaculation Treatment Market 2024-2028 - Product Thumbnail Image

Global Premature Ejaculation Treatment Market 2024-2028

  • Report
  • October 2023
  • 167 Pages
  • Global
From
Erectile Dysfunction Drugs Market By Products, By Mode of Administration, By Distribution Channels: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Erectile Dysfunction Drugs Market By Products, By Mode of Administration, By Distribution Channels: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • April 2023
  • 417 Pages
  • Global
From
Avanafil Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Avanafil Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • April 2023
  • 81 Pages
  • Global
From
Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Cystic Fibrosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • July 2022
  • 112 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Erectile Dysfunction Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029 - Product Thumbnail Image

Erectile Dysfunction Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029

  • Report
  • November 2021
  • 109 Pages
  • Global
From
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pancrelipase Market By Application, By Age, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Pancrelipase Market By Application, By Age, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 157 Pages
  • Global
From
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Global Market Report 2024 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Exocrine Pancreatic Insufficiency Global Market Report 2024 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Exocrine pancreatic insufficiency (EPI)?Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027) - Product Thumbnail Image

Exocrine pancreatic insufficiency (EPI)?Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

  • Report
  • June 2022
  • 111 Pages
  • Global
From
Binge Eating Disorder - Pipeline Review, H2 2020 - Product Thumbnail Image

Binge Eating Disorder - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 48 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1101 Pages
  • Global
From
Loading Indicator